EP1776099
Aðferðir til að bæta lífaðgengi renínlata.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
2.8.2005EP published:
25.11.2009EP application number:
05769973.8
EP translation filed:
29.12.2009Grant published:
15.1.2010EPO information:
European Patent Register
Max expiry date:
1.8.2025Expiry date:
1.8.2013
Title:
METHODS FOR IMPROVING BIOAVAILABILITY OF A RENIN INHIBITOR
Timeline
Today
2.8.2005EP application
25.11.2009EP Publication
29.12.2009Translation submitted
15.1.2010Registration published
1.8.2013Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
CAMENISCH, Gian, P.Address:
Riehen, CH
Name:
GROSS, GerhardAddress:
Lörrach, DE
Name:
OTTINGER, IsabelAddress:
Freiburg, DE
Name:
WASMUTH, DanielAddress:
Bättwil-Flüh, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
598700 PDate:
3.8.2004Country:
US
Classification
Categories:
A61K 31/165, A61K 38/13, A61P 9/00, A61P 9/12
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 29.7.2010
Expires: 31.8.2011
Payer: Árnason Faktor
Number: 7
Paid: 4.8.2011
Expires: 1.8.2012
Payer: Árnason Faktor
Number: 8
Paid: 27.8.2012
Expires: 1.8.2013
Payer: Árnason Faktor